After NAC, the pCR rate was 25.8% (247/956) and this rate was different according to BC subtype (luminal: 6.8% (28/410); TNBC: 39.7% (121/305), HER2-positive: 40.7% (98/241), p < 0.001). The gene discussed is ERBB2; the disease is breast cancer.